Comparative antimicrobial activity of piperacillin-tazobactam tested agaisnt more than 5000 recent clinical isolates from five medical centers : a reevaluation after five years
- Author
- MARSHALL, S. A1 ; ALDRIDGE, K. E; ALLEN, S. D; FUCHS, P. C; GERLACH, E.H; JONES, R. N1
[1] Univ. Iowa coll. medicine, Iowa City IA 52242, United States - Source
Diagnostic microbiology and infectious disease. 1995, Vol 21, Num 3, pp 153-168 ; ref : 1 p.1/2
- CODEN
- DMIDDZ
- ISSN
- 0732-8893
- Scientific domain
- Microbiology, infectious diseases; Pharmacology drugs
- Publisher
- Elsevier, New York, NY
- Publication country
- United States
- Document type
- Article
- Language
- English
- Keyword (fr)
- Antibactérien Association médicamenteuse Bactérie Concentration minimale inhibitrice Etude comparative In vitro Isolat clinique Pipéracilline Spectre activité Tazobactam Test sensibilité médicamenteuse β Lactame Antibiotique Enzyme Hydrolases Inhibiteur enzyme Pénicilline dérivé β-Lactamase
- Keyword (en)
- Antibacterial agent Drug combination Bacteria Minimum inhibitory concentration Comparative study In vitro Clinical isolate Activity spectrum Drug susceptibility test Antibiotic Enzyme Hydrolases Enzyme inhibitor Penicillin derivatives β-Lactamase
- Keyword (es)
- Antibacteriano Asociación medicamentosa Bacteria Concentración mínima inhibidora Estudio comparativo In vitro Aislado clinico Espectro actividad Prueba sensibilidad medicamentosa Antibiótico Enzima Hydrolases Inhibidor enzima Penicilinas β-Lactamase
- Classification
- Pascal
- 002 Biological and medical sciences / 002B Medical sciences / 002B02 Pharmacology. Drug treatments / 002B02S Antibiotics. Antiinfectious agents. Antiparasitic agents / 002B02S02 Antibacterial agents
- Discipline
- Pharmacological treatments
- Origin
- Inist-CNRS
- Database
- PASCAL
- INIST identifier
- 3586136
Sauf mention contraire ci-dessus, le contenu de cette notice bibliographique peut être utilisé dans le cadre d’une licence CC BY 4.0 Inist-CNRS / Unless otherwise stated above, the content of this bibliographic record may be used under a CC BY 4.0 licence by Inist-CNRS / A menos que se haya señalado antes, el contenido de este registro bibliográfico puede ser utilizado al amparo de una licencia CC BY 4.0 Inist-CNRS
Access to the document
Install on your browser
DOI
10.1016/0732-8893(95)00019-7 
https://dx.doi.org/10.1016/0732-8893(95)00019-7
"O:13:\"PanistOpenUrl\":36:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000idc\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:28:\"10.1016\/0732-8893(95)00019-7\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:176:\"Comparative antimicrobial activity of piperacillin-tazobactam tested agaisnt more than 5000 recent clinical isolates from five medical centers : a reevaluation after five years\";s:9:\"\u0000*\u0000jtitle\";s:46:\"Diagnostic microbiology and infectious disease\";s:9:\"\u0000*\u0000stitle\";s:29:\"Diagn. microbiol. infect. dis\";s:7:\"\u0000*\u0000date\";s:4:\"1995\";s:9:\"\u0000*\u0000volume\";s:2:\"21\";s:8:\"\u0000*\u0000issue\";s:1:\"3\";s:8:\"\u0000*\u0000spage\";s:3:\"153\";s:8:\"\u0000*\u0000epage\";s:3:\"168\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0732-8893\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:8:\"MARSHALL\";s:10:\"\u0000*\u0000aufirst\";s:4:\"S. A\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:5:{i:0;s:14:\"ALDRIDGE, K. E\";i:1;s:11:\"ALLEN, S. D\";i:2;s:11:\"FUCHS, P. C\";i:3;s:12:\"GERLACH, E.H\";i:4;s:11:\"JONES, R. N\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"DMIDDZ\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:176:\"Comparative antimicrobial activity of piperacillin-tazobactam tested agaisnt more than 5000 recent clinical isolates from five medical centers : a reevaluation after five years\";s:8:\"\u0000*\u0000place\";s:12:\"New York, NY\";s:6:\"\u0000*\u0000pub\";s:8:\"Elsevier\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:0:\"\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Panist access
"O:12:\"IstexOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:28:\"10.1016\/0732-8893(95)00019-7\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:176:\"Comparative antimicrobial activity of piperacillin-tazobactam tested agaisnt more than 5000 recent clinical isolates from five medical centers : a reevaluation after five years\";s:9:\"\u0000*\u0000jtitle\";s:46:\"Diagnostic microbiology and infectious disease\";s:9:\"\u0000*\u0000stitle\";s:29:\"Diagn. microbiol. infect. dis\";s:7:\"\u0000*\u0000date\";s:4:\"1995\";s:9:\"\u0000*\u0000volume\";s:2:\"21\";s:8:\"\u0000*\u0000issue\";s:1:\"3\";s:8:\"\u0000*\u0000spage\";s:3:\"153\";s:8:\"\u0000*\u0000epage\";s:3:\"168\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0732-8893\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:8:\"MARSHALL\";s:10:\"\u0000*\u0000aufirst\";s:4:\"S. A\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:5:{i:0;s:14:\"ALDRIDGE, K. E\";i:1;s:11:\"ALLEN, S. D\";i:2;s:11:\"FUCHS, P. C\";i:3;s:12:\"GERLACH, E.H\";i:4;s:11:\"JONES, R. N\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"DMIDDZ\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:176:\"Comparative antimicrobial activity of piperacillin-tazobactam tested agaisnt more than 5000 recent clinical isolates from five medical centers : a reevaluation after five years\";s:8:\"\u0000*\u0000place\";s:12:\"New York, NY\";s:6:\"\u0000*\u0000pub\";s:8:\"Elsevier\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:0:\"\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Istex access
"O:16:\"UnpaywallOpenUrl\":35:{s:8:\"\u0000*\u0000email\";s:27:\"assistance-portail@inist.fr\";s:6:\"\u0000*\u0000fmt\";N;s:6:\"\u0000*\u0000doi\";s:28:\"10.1016\/0732-8893(95)00019-7\";s:6:\"\u0000*\u0000pii\";N;s:7:\"\u0000*\u0000pmid\";N;s:9:\"\u0000*\u0000atitle\";N;s:9:\"\u0000*\u0000jtitle\";N;s:9:\"\u0000*\u0000stitle\";N;s:7:\"\u0000*\u0000date\";N;s:9:\"\u0000*\u0000volume\";N;s:8:\"\u0000*\u0000issue\";N;s:8:\"\u0000*\u0000spage\";N;s:8:\"\u0000*\u0000epage\";N;s:8:\"\u0000*\u0000pages\";N;s:7:\"\u0000*\u0000issn\";N;s:8:\"\u0000*\u0000eissn\";N;s:9:\"\u0000*\u0000aulast\";N;s:10:\"\u0000*\u0000aufirst\";N;s:9:\"\u0000*\u0000auinit\";N;s:10:\"\u0000*\u0000auinitm\";N;s:5:\"\u0000*\u0000au\";N;s:9:\"\u0000*\u0000aucorp\";N;s:7:\"\u0000*\u0000isbn\";N;s:8:\"\u0000*\u0000coden\";N;s:8:\"\u0000*\u0000genre\";N;s:7:\"\u0000*\u0000part\";N;s:9:\"\u0000*\u0000btitle\";N;s:8:\"\u0000*\u0000title\";N;s:8:\"\u0000*\u0000place\";N;s:6:\"\u0000*\u0000pub\";N;s:10:\"\u0000*\u0000edition\";N;s:9:\"\u0000*\u0000tpages\";N;s:9:\"\u0000*\u0000series\";N;s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";N;}"
Unpaywall access
"O:16:\"EuropePMCOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:28:\"10.1016\/0732-8893(95)00019-7\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:176:\"Comparative antimicrobial activity of piperacillin-tazobactam tested agaisnt more than 5000 recent clinical isolates from five medical centers : a reevaluation after five years\";s:9:\"\u0000*\u0000jtitle\";s:46:\"Diagnostic microbiology and infectious disease\";s:9:\"\u0000*\u0000stitle\";s:29:\"Diagn. microbiol. infect. dis\";s:7:\"\u0000*\u0000date\";s:4:\"1995\";s:9:\"\u0000*\u0000volume\";s:2:\"21\";s:8:\"\u0000*\u0000issue\";s:1:\"3\";s:8:\"\u0000*\u0000spage\";s:3:\"153\";s:8:\"\u0000*\u0000epage\";s:3:\"168\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0732-8893\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:8:\"MARSHALL\";s:10:\"\u0000*\u0000aufirst\";s:4:\"S. A\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:5:{i:0;s:14:\"ALDRIDGE, K. E\";i:1;s:11:\"ALLEN, S. D\";i:2;s:11:\"FUCHS, P. C\";i:3;s:12:\"GERLACH, E.H\";i:4;s:11:\"JONES, R. N\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"DMIDDZ\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:176:\"Comparative antimicrobial activity of piperacillin-tazobactam tested agaisnt more than 5000 recent clinical isolates from five medical centers : a reevaluation after five years\";s:8:\"\u0000*\u0000place\";s:12:\"New York, NY\";s:6:\"\u0000*\u0000pub\";s:8:\"Elsevier\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:0:\"\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Europe PubMed Central access
"O:11:\"BaseOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:28:\"10.1016\/0732-8893(95)00019-7\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:176:\"Comparative antimicrobial activity of piperacillin-tazobactam tested agaisnt more than 5000 recent clinical isolates from five medical centers : a reevaluation after five years\";s:9:\"\u0000*\u0000jtitle\";s:46:\"Diagnostic microbiology and infectious disease\";s:9:\"\u0000*\u0000stitle\";s:29:\"Diagn. microbiol. infect. dis\";s:7:\"\u0000*\u0000date\";s:4:\"1995\";s:9:\"\u0000*\u0000volume\";s:2:\"21\";s:8:\"\u0000*\u0000issue\";s:1:\"3\";s:8:\"\u0000*\u0000spage\";s:3:\"153\";s:8:\"\u0000*\u0000epage\";s:3:\"168\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0732-8893\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:8:\"MARSHALL\";s:10:\"\u0000*\u0000aufirst\";s:4:\"S. A\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:5:{i:0;s:14:\"ALDRIDGE, K. E\";i:1;s:11:\"ALLEN, S. D\";i:2;s:11:\"FUCHS, P. C\";i:3;s:12:\"GERLACH, E.H\";i:4;s:11:\"JONES, R. N\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"DMIDDZ\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:176:\"Comparative antimicrobial activity of piperacillin-tazobactam tested agaisnt more than 5000 recent clinical isolates from five medical centers : a reevaluation after five years\";s:8:\"\u0000*\u0000place\";s:12:\"New York, NY\";s:6:\"\u0000*\u0000pub\";s:8:\"Elsevier\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:0:\"\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Base Search access
"O:12:\"ArXivOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:28:\"10.1016\/0732-8893(95)00019-7\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:176:\"Comparative antimicrobial activity of piperacillin-tazobactam tested agaisnt more than 5000 recent clinical isolates from five medical centers : a reevaluation after five years\";s:9:\"\u0000*\u0000jtitle\";s:46:\"Diagnostic microbiology and infectious disease\";s:9:\"\u0000*\u0000stitle\";s:29:\"Diagn. microbiol. infect. dis\";s:7:\"\u0000*\u0000date\";s:4:\"1995\";s:9:\"\u0000*\u0000volume\";s:2:\"21\";s:8:\"\u0000*\u0000issue\";s:1:\"3\";s:8:\"\u0000*\u0000spage\";s:3:\"153\";s:8:\"\u0000*\u0000epage\";s:3:\"168\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0732-8893\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:8:\"MARSHALL\";s:10:\"\u0000*\u0000aufirst\";s:4:\"S. A\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:5:{i:0;s:14:\"ALDRIDGE, K. E\";i:1;s:11:\"ALLEN, S. D\";i:2;s:11:\"FUCHS, P. C\";i:3;s:12:\"GERLACH, E.H\";i:4;s:11:\"JONES, R. N\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"DMIDDZ\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:176:\"Comparative antimicrobial activity of piperacillin-tazobactam tested agaisnt more than 5000 recent clinical isolates from five medical centers : a reevaluation after five years\";s:8:\"\u0000*\u0000place\";s:12:\"New York, NY\";s:6:\"\u0000*\u0000pub\";s:8:\"Elsevier\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:0:\"\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
arXiv access
